Strategic Plan and Research Agenda for Medical Countermeasures Against Radiological and Nuclear Threats Progress Report: 2005-2011 and Future Research Directions: 2012-2016 [open pdf - 498KB]
"In 2003, the White House Office of Science and Technology Policy and White House Homeland Security Council jointly convened a Radiological/Nuclear Threat Countermeasures Working Group to develop a list of priority research areas, an assessment of the current status of radiation diagnostics and biodosimetry, and product requirements statements for candidate radiation medical countermeasures (MCMs). The interagency consensus developed through this process was finally published in 2005. In 2004, building on this interagency consensus, the U.S. Department of Health and Human Services (HHS) directed the National Institute of Allergy and Infectious Diseases (NIAID) to develop a strategic plan and research agenda to guide efforts at the National Institutes of Health (NIH) to develop MCMs against radiological and nuclear threats. Previously, no federal agency had the mission to develop such products for civilian populations. Taking the Working Group Final Report and reports from subsequent focused workshops sponsored by NIAID and the National Cancer Institute (NCI) as a starting point, NIAID developed a draft research agenda for the new NIH Radiation Countermeasures Program (RCP). [...] NIH has made substantial progress toward addressing the specific research goals and recommendations identified in the four priority areas of the Strategic Plan and Research Agenda, thereby increasing the breadth and depth of research on radiation MCMs. These are described as 'Continuing Research Goals' in each section of this report. Based on the knowledge and experience gained in the subsequent 5 years, 'Expanded/Revised Research Goals' representing a refinement and more in-depth, mature understanding of program requirements have been identified to establish future directions for 2012--2016. As scientific, research and programmatic gaps are identified and assessed, program adjustments are instituted and/or new initiatives are developed."
National Institute of Allergy and Infectious Diseases :http://www.niaid.nih.gov/